Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Stryker shares rise as investors focus on recent vascular M&A and upcoming conference update

None

Stryker (SYK) is up 3.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to investors re-rating the stock after Stryker’s recent close of its Amplitude Vascular Systems acquisition and fresh clarity on the deal’s potential value. The shares may also be getting a lift ahead of management’s scheduled healthcare conference presentation, which could reinforce the company’s full-year outlook and cyber-recovery progress.

Details:

  • Stryker said it completed the acquisition of Amplitude Vascular Systems on May 7, 2026, adding a next-generation intravascular lithotripsy platform aimed at treating complex peripheral arterial disease.
  • Stryker’s quarterly filing disclosed the transaction’s structure at roughly $435 million in cash plus up to $400 million tied to future milestones, implying total consideration that could reach about $835 million.
  • In its April 30, 2026 first-quarter update, Stryker reiterated full-year 2026 guidance for organic sales growth of 8.0% to 9.5% and adjusted EPS of $14.90 to $15.10, while highlighting rapid recovery actions following a cyber incident.
  • Stryker is scheduled to present at the Bank of America Securities 2026 Global Healthcare Conference on May 13, 2026, a potential near-term touchpoint for investors watching demand trends and M&A integration.
  • Sources:

    Stryker Investor Relations, Stryker (Q1 2026 earnings release), MassDevice

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $SYK Insider Trading Activity

    SYK Insider Trades

    $SYK insiders have traded $SYK stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.

    Here’s a breakdown of recent trading of $SYK stock by insiders over the last 6 months:

    • RONDA E STRYKER has made 0 purchases and 18 sales selling 500,000 shares for an estimated $181,719,268.
    • WILLIAM E JR BERRY (VP, Chief Accounting Officer) sold 1,953 shares for an estimated $713,801
    • JAMES ANDREW PIERCE (Group President) sold 475 shares for an estimated $175,214
    • PRESTON WENDELL WELLS (VP, Chief Financial Officer) sold 165 shares for an estimated $60,370

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive SYK Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $SYK Hedge Fund Activity

    We have seen 1,032 institutional investors add shares of $SYK stock to their portfolio, and 1,080 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $SYK Government Contracts

    We have seen $48,061,736 of award payments to $SYK over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

    $SYK Congressional Stock Trading

    Members of Congress have traded $SYK stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

    Here’s a breakdown of recent trading of $SYK stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $SYK Analyst Ratings

    Wall Street analysts have issued reports on $SYK in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Needham issued a "Buy" rating on 05/01/2026
    • BTIG issued a "Buy" rating on 05/01/2026
    • Wells Fargo issued a "Overweight" rating on 11/14/2025

    To track analyst ratings and price targets for $SYK, check out Quiver Quantitative's $SYK forecast page.

    $SYK Price Targets

    Multiple analysts have issued price targets for $SYK recently. We have seen 14 analysts offer price targets for $SYK in the last 6 months, with a median target of $397.0.

    Here are some recent targets:

    • Matt Miksic from Barclays set a target price of $394.0 on 05/04/2026
    • Richard Newitter from Truist Securities set a target price of $330.0 on 05/04/2026
    • Mike Matson from Needham set a target price of $418.0 on 05/01/2026
    • Ryan Zimmerman from BTIG set a target price of $379.0 on 05/01/2026
    • Vijay Kumar from Evercore ISI Group set a target price of $355.0 on 05/01/2026
    • Larry Biegelsen from Wells Fargo set a target price of $418.0 on 05/01/2026
    • Robbie Marcus from JP Morgan set a target price of $400.0 on 05/01/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles